previously analysed the dermoscopic criteria associated with BRAF and NRAS mutation status in primary cutaneous MM, very little is known about the dermoscopic and prognostic differences between V600E and V600K variants and the correlation of dermoscopic features and mutational burden.9, 10, 11. The gene discussed is BRAF; the disease is Miyoshi myopathy.